Found 22 results
Author Title Type [ Year(Asc)]
Filters: Author is Belshe, RB  [Clear All Filters]
2000
J. C. King, Treanor, J., Fast, P. E., Wolff, M. C., Yan, L., Iacuzio, D., Readmond, B., O’Brien, D., Mallon, K., Highsmith, W. E., Lambert, J. S., and Belshe, R. B., Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults, J Infec Dis, vol. 181, pp. 725-8, 2000.
S. Sabbaj, Mulligan, M. J., Hsieh, R. H., Belshe, R. B., and , Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group, AIDS Res HumRetroviruses, vol. 14, pp. 1365-74, 2000.
R. B. Belshe, Gruber, W., Mendelman, P. M., Cho, I., Reisinger, K., Block, S., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., King, J., Kotloff, K., Bernstein, D. I., Hayden, F. G., Zangwill, K., Yan, L., and Wolff, M. C., Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine, J Pediatric, vol. 136, pp. 168-175, 2000.
I. M. Longini, Halloran, M. E., Nizam, A., Wolff, M. C., Mendelman, P. M., Fast, P. E., and Belshe, R. B., Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control, Vaccine, vol. 18, pp. 1902-9, 2000.
S. Sabbaj, Mulligan, M. J., Hsieh, R. H., Belshe, R. B., and , NIAID AIDS Vaccine Evaluation Group. Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp 120 prime-boost HIV-1 vaccine, AIDS Res HumRetroviruses, vol. 14, pp. 1365-74, 2000.